• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.

作者信息

Mathur Anthony, Fernández-Avilés Francisco, Dimmeler Stefanie, Hauskeller Christine, Janssens Stefan, Menasche Philippe, Wojakowski Wojtek, Martin John F, Zeiher Andreas

机构信息

Queen Mary University of London.

Hospital General Universitario Gregorio Marañón, Madrid.

出版信息

Eur Heart J. 2017 Oct 14;38(39):2930-2935. doi: 10.1093/eurheartj/ehw640.

DOI:10.1093/eurheartj/ehw640
PMID:28204458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5837487/
Abstract
摘要

相似文献

1
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.欧洲心脏病学会特别工作组关于自体成体干细胞用于治疗急性心肌梗死和心力衰竭的临床研究的共识：2016年更新版
Eur Heart J. 2017 Oct 14;38(39):2930-2935. doi: 10.1093/eurheartj/ehw640.
2
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.欧洲心脏病学会特别工作组关于使用自体成年干细胞修复心脏的临床研究的共识。
Eur Heart J. 2006 Jun;27(11):1338-40. doi: 10.1093/eurheartj/ehi793. Epub 2006 Mar 16.
3
Adult Stem Cell Therapy for Cardiac Repair in Patients After Acute Myocardial Infarction Leading to Ischemic Heart Failure: An Overview of Evidence from the Recent Clinical Trials.急性心肌梗死后导致缺血性心力衰竭患者的心脏修复成人干细胞疗法：近期临床试验证据综述
Curr Cardiol Rev. 2017;13(3):223-231. doi: 10.2174/1573403X13666170502103833.
4
Mainz 1986: the European Society of Cardiology changes its course.
Eur Heart J. 1987 Sep;8 Suppl F:1-7. doi: 10.1093/eurheartj/8.suppl_f.1.
5
Stem cells: Cell therapy for cardiac repair: what is needed to move forward?干细胞：用于心脏修复的细胞疗法：向前发展需要什么？
Nat Rev Cardiol. 2017 May;14(5):257-258. doi: 10.1038/nrcardio.2017.38. Epub 2017 Mar 31.
6
Skeletal myoblasts and cardiac repair.骨骼肌成肌细胞与心脏修复。
J Mol Cell Cardiol. 2008 Oct;45(4):545-53. doi: 10.1016/j.yjmcc.2007.11.009. Epub 2007 Dec 4.
7
Doubts over heart stem-cell therapy.对心脏干细胞疗法的质疑。
Nature. 2014 May 1;509(7498):15-6. doi: 10.1038/509015a.
8
Current status of the role of stem cells in myocardial biology and repair.干细胞在心肌生物学和修复中的作用的现状。
Cardiovasc Pathol. 2011 Sep-Oct;20(5):297-301. doi: 10.1016/j.carpath.2010.08.004. Epub 2010 Sep 16.
9
Somatic stem cell transplantation for the failing heart.用于衰竭心脏的体干细胞移植。
Scand J Surg. 2007;96(2):131-9. doi: 10.1177/145749690709600208.
10
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.用于慢性缺血性心脏病和充血性心力衰竭的干细胞疗法。
Cochrane Database Syst Rev. 2016 Dec 24;12(12):CD007888. doi: 10.1002/14651858.CD007888.pub3.

引用本文的文献

1
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective.对抗心血管疾病的再生医学与纳米技术方法：最新进展与未来展望
Curr Stem Cell Res Ther. 2025;20(1):50-71. doi: 10.2174/011574888X263530230921074827.
2
The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review.组织工程用于再生目的的伦理影响：系统评价。
Tissue Eng Part B Rev. 2023 Apr;29(2):167-187. doi: 10.1089/ten.TEB.2022.0033. Epub 2022 Oct 20.
3
On 3 legs shall we stand: Combined innovation for treatment of ischemic cardiomyopathy.我们将依靠三条支柱：缺血性心肌病治疗的联合创新。
JTCVS Open. 2021 May 6;7:223-227. doi: 10.1016/j.xjon.2021.03.025. eCollection 2021 Sep.
4
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.一项关于自体间充质基质细胞和 c-kit 阳性心肌细胞单独或联合应用于缺血性心力衰竭患者的 II 期研究：CCTRN CONCERT-HF 试验。
Eur J Heart Fail. 2021 Apr;23(4):661-674. doi: 10.1002/ejhf.2178. Epub 2021 Apr 13.
5
Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.预处理和基因修饰的干细胞治疗心肌梗死。
Int J Mol Sci. 2020 Oct 2;21(19):7301. doi: 10.3390/ijms21197301.
6
[Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure.[Zr]Zr-DBN 标记的心功能再生干细胞可用于心力衰竭。
Nucl Med Biol. 2020 Nov-Dec;90-91:23-30. doi: 10.1016/j.nucmedbio.2020.09.001. Epub 2020 Sep 9.
7
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.冠状动脉内注入骨髓来源的单个核细胞对急性心肌梗死全因死亡率的影响：BAMI试验
Eur Heart J. 2020 Oct 7;41(38):3702-3710. doi: 10.1093/eurheartj/ehaa651.
8
Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives.干细胞和细胞外囊泡在急救护理中的治疗应用：未来展望。
Stem Cell Rev Rep. 2021 Apr;17(2):390-410. doi: 10.1007/s12015-020-10029-2.
9
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction.单核细胞移植治疗心肌梗死患者的短期和长期疗效的荟萃分析。
Am Heart J. 2020 Feb;220:155-175. doi: 10.1016/j.ahj.2019.09.005. Epub 2019 Nov 11.
10
Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.所有干细胞都一样吗？基于临床前干细胞疗法治疗支气管肺发育不良的系统评价、证据图谱和荟萃分析。
Stem Cells Transl Med. 2020 Feb;9(2):158-168. doi: 10.1002/sctm.19-0193. Epub 2019 Nov 20.

本文引用的文献

1
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.同种异体心脏干细胞实现心肌再生（ALLSTAR）试验：原理与设计
Cell Transplant. 2017 Feb 16;26(2):205-214. doi: 10.3727/096368916X692933. Epub 2016 Aug 18.
2
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.Ixmyelocel-T 治疗缺血性心力衰竭患者的前瞻性随机双盲试验。
Lancet. 2016 Jun 11;387(10036):2412-21. doi: 10.1016/S0140-6736(16)30137-4. Epub 2016 Apr 5.
3
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.联合细胞疗法对慢性缺血性心肌病的协同作用。
J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999. doi: 10.1016/j.jacc.2015.08.879.
4
Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.细胞因子联合成人自体骨髓祖细胞治疗非缺血性扩张型心肌病患者的随机试验：再生-DCM临床试验
Eur Heart J. 2015 Nov 21;36(44):3061-9. doi: 10.1093/eurheartj/ehv390. Epub 2015 Sep 2.
5
Cyclosporine before PCI in Patients with Acute Myocardial Infarction.急性心肌梗死患者经皮冠状动脉介入治疗前的环孢素。
N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.
6
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.同种异体间充质前体细胞治疗缺血性或非缺血性心力衰竭患者的 II 期剂量递增研究。
Circ Res. 2015 Aug 28;117(6):576-84. doi: 10.1161/CIRCRESAHA.115.306332. Epub 2015 Jul 6.
7
Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report.人胚胎干细胞来源的心肌祖细胞治疗严重心力衰竭：首例临床病例报告。
Eur Heart J. 2015 Aug 7;36(30):2011-7. doi: 10.1093/eurheartj/ehv189. Epub 2015 May 19.
8
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).骨髓间充质基质细胞治疗严重缺血性心力衰竭患者：一项随机安慰剂对照试验（MSC-HF 试验）。
Eur Heart J. 2015 Jul 14;36(27):1744-53. doi: 10.1093/eurheartj/ehv136. Epub 2015 Apr 29.
9
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.基于个体患者数据的急性心肌梗死患者细胞心肌研究的荟萃分析（ACCRUE）
Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.
10
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial.缺血性心肌病患者的脂肪来源再生细胞：PRECISE试验。
Am Heart J. 2014 Jul;168(1):88-95.e2. doi: 10.1016/j.ahj.2014.03.022. Epub 2014 Apr 5.